The boston keratoprosthesis type i in mucous membrane pemphigoid

Cornea

Volumn 32, Issue 7, 2013, Pages 956-961

  Palioura, Sotiria ^a   Kim, Bryan ^b   Dohlman, Claes H ^a   Chodosh, James ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Boston keratoprosthesis; Long term outcomes; Mucous membrane pemphigoid; Ocular cicatricial pemphigoid

Indexed keywords

PREDNISOLONE ACETATE; VANCOMYCIN;

ADULT; AGED; ARTICLE; BLINDNESS; BOSTON KERATOPROSTHESIS TYPE I; CHOROID DETACHMENT; CLINICAL ARTICLE; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; KERATOPROSTHESIS; MALE; MUCOUS MEMBRANE PEMPHIGOID; OCULAR SURFACE DISEASE; OUTCOME ASSESSMENT; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTHESIS FIXATION; RETINA DETACHMENT; RETROSPECTIVE STUDY; SURGICAL PATIENT; VISUAL ACUITY; VITRITIS;

AGED; AGED, 80 AND OVER; ANESTHESIA, GENERAL; CONJUNCTIVAL DISEASES; CORNEAL DISEASES; FEMALE; GRAFT SURVIVAL; HUMANS; MALE; MIDDLE AGED; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; POSTOPERATIVE COMPLICATIONS; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 84879101223     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318286fd73     Document Type: Article

References (27)

1. Chan LS, Ahmed AR, Anhalt GJ, et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol. 2002;138:370-379.
2. Messmer EM, Hintschich CR, Partscht K, et al. [Ocular cicatricial pemphigoid. Retrospective analysis of risk factors and complications]. Ophthalmologe. 2000;97:113-120.
3. Kirzhner M, Jakobiec FA. Ocular cicatricial pemphigoid: a review of clinical features, immunopathology, differential diagnosis, and current management. Semin Ophthalmol. 2011;26:270-277.
4. Tugal-Tutkun I, Akova YA, Foster CS. Penetrating keratoplasty in cicatrizing conjunctival diseases. Ophthalmology. 1995;102:576-585.
5. Khan BF, Harissi-Dagher M, Khan DM, et al. Advances in Boston keratoprosthesis: enhancing retention and prevention of infection and inflammation. Int Ophthalmol Clin. 2007;47:61-71.
6. Zerbe BL, Belin MW, Ciolino JB. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology. 2006;113:1779-1784.
7. Bradley JC, Hernandez EG, Schwab IR, et al. Boston type 1 keratoprosthesis: the University of California Davis experience. Cornea. 2009;28: 321-327.
8. Chew HF, Ayres BD, Hammersmith KM, et al. Boston keratoprosthesis outcomes and complications. Cornea. 2009;28:989-996.
9. Akpek EK, Harissi-Dagher M, Petrarca R, et al. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study. Am J Ophthalmol. 2007;144:227-231.
10. Aldave AJ, Sangwan VS, Basu S, et al. International results with the Boston type I keratoprosthesis. Ophthalmology. 2012;119:1530-1538.
11. Pujari S, Siddique SS, Dohlman CH, et al. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience. Cornea. 2011;30:1298-1303.
12. Khan B, Dudenhoefer EJ, Dohlman CH. Keratoprosthesis: an update. Curr Opin Ophthalmol. 2001;12:282-287.
13. Durand ML, Dohlman CH. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea. 2009;28:896-901.
14. Doane MG, Dohlman CH, Bearse G. Fabrication of a keratoprosthesis. Cornea. 1996;15:179-184.
15. Dohlman CH, Waller SG, Netland PA. Keratoprosthesis Surgery. In: Lindquist TD, Lindstrom RL, ed. Ophthalmic Surgery Update. Chicago, IL: Mosby; 1997:1-31.
16. Dohlman CH, Nouri M. Keratoprosthesis surgery. In: Foster CS, Azar DT, Dohlman CH, ed. Smolin and Thoft's, The Cornea. Philadelphia, Pennsylvania: Lippincott, Williams & Wilkins; 2005:1085-1095.
17. Nouri M, Terada H, Alfonso EC, et al. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol. 2001;119:484-489.
18. Yaghouti F, Nouri M, Abad JC, et al. Keratoprosthesis: preoperative prognostic categories. Cornea. 2001;20:19-23.
19. Ray S, Khan BF, Dohlman CH, et al. Management of vitreoretinal complications in eyes with permanent keratoprosthesis. Arch Ophthalmol. 2002;120:559-566.
20. Falcinelli G, Falsini B, Taloni M, et al. Modified osteo- odontokeratoprosthesis for treatment of corneal blindness: long-term anatomical and functional outcomes in 181 cases. Arch Ophthalmol. 2005;123: 1319-1329.
21. Hille K, Hille A, Ruprecht KW. Medium term results in keratoprostheses with biocompatible and biological haptic. Graefes Arch Clin Exp Ophthalmol. 2006;244:696-704.
22. Liu C, Okera S, Tandon R, et al. Visual rehabilitation in end-stage inflammatory ocular surface disease with the osteo-odonto-keratoprosthesis: results from the UK. Br J Ophthalmol. 2008;92:1211-1217.
23. Fukuda M, Hamada S, Liu C, et al. Osteo-odonto-keratoprosthesis in Japan. Cornea. 2008;27(suppl 1):S56-S61.
24. Michael R, Charoenrook V, de la Paz MF, et al. Long-term functional and anatomical results of osteo-and osteoodonto-keratoprosthesis. Graefes Arch Clin Exp Ophthalmol. 2008;246:1133-1137.
25. Tan DT, Tay AB, Theng JT, et al. Keratoprosthesis surgery for end-stage corneal blindness in asian eyes. Ophthalmology. 2008;115:503-510.
26. Iyer G, Pillai VS, Srinivasan B, et al.Modified osteo-odonto keratoprosthesis-the Indian experience-results of the first 50 cases. Cornea. 2010;29: 771-776.
27. De La Paz MF, De Toledo JA, Charoenrook V, et al. Impact of clinical factors on the long-term functional and anatomic outcomes of osteoodonto-keratoprosthesis and tibial bone keratoprosthesis. Am J Ophthalmol. 2011;151:829-839.